A clinical approach to the hyperlipidemias.
D000535:Aluminum; D006528:Carcinoma, Hepatocellular / Q000150:complications; D002779:Cholestasis / Q000150:complications; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D048909:Diabetes Complications; D004035:Diet Therapy; D004040:Dietary Carbohydrates / Q000009:adverse effects / Q000378:metabolism; D004041:Dietary Fats / Q000009:adverse effects / Q000378:metabolism; D004586:Electrophoresis; D005128:Eye Diseases / Q000209:etiology; D005224:Fats, Unsaturated; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006949:Hyperlipidemias / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000628:therapy; D008074:Lipoproteins / Q000032:analysis; D008113:Liver Neoplasms / Q000150:complications; D009230:Myxedema / Q000150:complications; D009404:Nephrotic Syndrome / Q000150:complications; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000150:complications
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D005224:Fats, Unsaturated; D008074:Lipoproteins; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D000535:Aluminum